Latest Stories
3 Reasons to Avoid GEV and 1 Stock to Buy Instead
GE Vernova’s 28.4% return over the past six months has outpaced the S&P 500 by 22.5%, and its stock price has climbed to $802.45 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons to Sell YUMC and 1 Stock to Buy Instead
Yum China’s 23.5% return over the past six months has outpaced the S&P 500 by 17.6%, and its stock price has climbed to $54.95 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
2 Reasons to Like UHS (and 1 Not So Much)
Over the past six months, Universal Health Services has been a great trade, beating the S&P 500 by 26.9%. Its stock price has climbed to $235.83, representing a healthy 32.8% increase. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons LEVI is Risky and 1 Stock to Buy Instead
Levi's has been treading water for the past six months, recording a small return of 4.8% while holding steady at $22.06.
AerSale (ASLE): Buy, Sell, or Hold Post Q3 Earnings?
Over the last six months, AerSale’s shares have sunk to $7.20, producing a disappointing 18.5% loss - a stark contrast to the S&P 500’s 5.9% gain. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
ResMed (RMD): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, ResMed’s shares (currently trading at $252.56) have posted a disappointing 11.7% loss, well below the S&P 500’s 5.9% gain. This might have investors contemplating their next move.
3 Reasons We’re Fans of DXP (DXPE)
DXP currently trades at $148.68 and has been a dream stock for shareholders. It’s returned 439% since February 2021, blowing past the S&P 500’s 73.7% gain. The company has also beaten the index over the past six months as its stock price is up 22.4%.
3 Reasons to Avoid NVST and 1 Stock to Buy Instead
Envista’s 39.5% return over the past six months has outpaced the S&P 500 by 33.6%, and its stock price has climbed to $28.97 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons KEY is Risky and 1 Stock to Buy Instead
KeyCorp’s 18.2% return over the past six months has outpaced the S&P 500 by 12.3%, and its stock price has climbed to $21.50 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
MediaAlpha (MAX): Buy, Sell, or Hold Post Q3 Earnings?
MediaAlpha has gotten torched over the last six months - since August 2025, its stock price has dropped 26.8% to $7.42 per share. This might have investors contemplating their next move.